Drug Patent Expirations in December 2010
Drug Patent Expirations in December 2010
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| CHILDREN’S MOTRIN | Mcneil Cons | ibuprofen | 5,215,755*PED | Dec 1, 2010 |
| JUNIOR STRENGTH MOTRIN | Mcneil Cons | ibuprofen | 5,215,755*PED | Dec 1, 2010 |
| MOTRIN | Mcneil Ped | ibuprofen | 5,215,755*PED | Dec 1, 2010 |
| ZYFLO CR | Cornerstone Therap | zileuton | 4,873,259 | Dec 9, 2010 |
| ZYFLO | Cornerstone Therap | zileuton | 4,873,259 | Dec 10, 2010 |
| ANDRODERM | Watson Labs | testosterone | 5,164,190 | Dec 11, 2010 |
| ANDRODERM | Watson Labs | testosterone | 5,152,997 | Dec 11, 2010 |
| OXYTROL | Watson Labs (utah) | oxybutynin | 5,164,190 | Dec 11, 2010 |
| ALORA | Watson Labs | estradiol | 5,164,190 | Dec 11, 2010 |
| ZANTAC 150 | Boehringer Ingelheim | ranitidine hydrochloride | 5,098,715 | Dec 20, 2010 |
| QUIXIN | Santen | levofloxacin | 5,053,407 | Dec 20, 2010 |
| IQUIX | Santen | levofloxacin | 5,053,407 | Dec 20, 2010 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com
Leave a Reply
Want to join the discussion?Feel free to contribute!